Cite
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
MLA
Ken Takasaki, et al. “Clinical Utilization of Postoperative Dendritic Cell Vaccine plus Activated T-Cell Transfer in Patients with Intrahepatic Cholangiocarcinoma.” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, no. 2, Aug. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79aa2af3c6b40ecc4129aa14cab3cec3&authtype=sso&custid=ns315887.
APA
Ken Takasaki, Koichi Shimizu, Nobuhiro Takeshita, Yoshihito Kotera, Masakazu Yamamoto, & Atsushi Aruga. (2011). Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 19(2).
Chicago
Ken Takasaki, Koichi Shimizu, Nobuhiro Takeshita, Yoshihito Kotera, Masakazu Yamamoto, and Atsushi Aruga. 2011. “Clinical Utilization of Postoperative Dendritic Cell Vaccine plus Activated T-Cell Transfer in Patients with Intrahepatic Cholangiocarcinoma.” Journal of Hepato-Biliary-Pancreatic Sciences 19 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....79aa2af3c6b40ecc4129aa14cab3cec3&authtype=sso&custid=ns315887.